Drug factory · FDA FEI 3006010798

Haupt Pharma Muenster GmbH

Schleebrueggenkamp 15, Muenster, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 20, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2012: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Drospirenone and EstetrolMakes it, tests it and packages it Mayne Pharma Inc. 51862-258
Ethinyl Estradiol and LevonorgestrelMakes it Ohm Laboratories Inc. 51660-572
Ethinyl Estradiol and NorgestimateMakes it, tests it and packages it Amneal Pharmaceuticals 69238-1551
NorethindroneMakes it Ohm Laboratories Inc. 51660-127

FDA inspection history

EndedResultProgramProblems noted
Nov 20, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 24, 2021No problems foundDrug Quality Assurance—
Jul 6, 2018Problems found, fixed voluntarilyDrug Quality Assurance3
Mar 21, 2014No problems foundDrug Quality Assurance—
Mar 30, 2012Problems found, fixed voluntarilyDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Jul 6, 2018 inspection

Registered with FDA for: analysis; label; manufacture; pack.